FDA Inspection
Biolog, Inc.Biolog, Inc. – FDA Inspection, Aug 15, 2024
Record Details
This FDA Inspection record concerns Biolog, Inc., with an inspection on August 15, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · eee69fbb-c71e-4bbf-8a5c-1f5c71a869d5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1246485
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(a)Approve or reject components, products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biolog, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biolog, Inc.
- FDA Inspection 1016850 - 2017-03-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.